Infectious Agents and Cancer

unofficial impact factor 2.33

This article is part of the supplement: Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research

Open Access Email this article to a friend

Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab

K Dunleavy*, RF Little, AS Wayne, N Grant, S Pittaluga, ES Jaffe, S Steinberg, R Yarchoan, J Carrasquillo, J Janik and WH Wilson

  • * Corresponding author: K Dunleavy

Infectious Agents and Cancer 2009, 4(Suppl 2):O9 doi:10.1186/1750-9378-4-S2-O9

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.